Issues in newborn screening

Genetic Testing

Volumn 7, Issue 2, 2003, Pages 131-134

  Saxena, Anita ^a,b  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b SGPG1 ^*  (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPETENCE; ERROR; ETHICS; GENETIC SCREENING; HEALTH PROGRAM; HUMAN; NEWBORN SCREENING; QUALITY CONTROL;

GENETICS AND REPRODUCTION;

FEMALE; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; NEONATAL SCREENING; PREGNANCY; PRENATAL DIAGNOSIS; QUALITY ASSURANCE, HEALTH CARE;

EID: 0037815405     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/109065703322146812     Document Type: Article

References (27)

1. BICKEL, H., GERRARD, J.W., and HICKMAN, E.M. (1954). Influence of phenylalanine intake on the chemistry and behaviour of a phenylketonuric child. Acta Pediatr. 432, 64-77.
2. BURKE, W., PINSKY, L.E., and PRESS, N.A. (2001). Categorising genetic tests to identify their ethical, legal and social implications (106). Am. J. Med. Genet. (Semin. Meg. Genet.), 233-240.
3. COLLINS, F.S. (1999). Shattuck lecture - Medical and societal consequences of the human genome project. N. Engl. J. Med. 341, 28-37.
4. COMMITTEE FOR THE STUDY OF INBORN ERRORS OF METABOLISM SCREENING PROGRAMS. (1975). Principles and Research. National Academy of Sciences, Washington, DC.
5. DANISH COUNCIL OF ETHICS. (1993a). Ethics and mapping of the human genome. Danish Council of Ethics, Copenhagen.
6. DANISH COUNCIL ON ETHICS. (1993b). Genetic testing. In Ethics and Mapping of the Human Genome. Danish Council on Ethics, Copenhagen, pp. 77-86.
7. DOBROWOLSKI, S.K., NAYLOR, E.W., BANAS, R., and THAKKAR, D. (1999). DNA chip technology and neonatal screening. Acta Paediatr. 88 (Suppl. 432), 61-64.
8. DODGE, J.A. (1999). Why screen for cystic fibrosis? A clinician's view. Acta Pediatr. 432, 28-32.
9. DUSSAULT, J.H. (1999). Relation of basic and clinical research on foetal and neonatal thyroid pathology to neonatal thyroid screening. Acta Pediatr. 432, 15-17.
10. ERBE, R.W., and LEVY, H.L. (2002). Neonatal screening. In Emery and Rimoin's Principles and Practice of Medical Genetics, 4th ed. D.L. Rimoin, J.M. Connor, R. Pyeritz, and B. Korf. (eds.). Churchill Livingstone, New York, pp. 826-841.
11. EVANS, M.I., and LEVY, H.L. (1999). The future of NBS belongs to obstetricians. Acta Paediatr. 88 (Suppl. 432), 55-57.
12. GUTHRIE, R., and SUSU, A. (1963). A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32, 338-343.
13. GUTHRIE, R., and SUSU, A. (1964). Routine screening for inborn errors in the newborn: "inhibition assays," "instant bacteria" and multiple tests. International Copenhagen Congress on Scientific Study of Mental Retardation Denmark, August 7-14.
14. HARRIS, H. (1963). Garrod's Inborn Errors Of Metabolism. Oxford University Press, London.
15. HERMEREN, G. (1999). Neonatal screening: ethical aspects. Acta Pediatr. 88 (Suppl. 432), 99-103.
16. KOPP, M.U., MELLO, A.J., and MANZ. A. (1998). Chemical amplification: continuous flow PCR on a chip. Science 380, 1046-1048.
17. LOEBER, G., WEBSTER, D., and AZNAREZ, A. (1999). Quality evaluation of newborn screening programs. Acta Pediatr. 88 (Suppl. 432), 3-6.
18. MANDL, K.D., FEIT, S., LARSON, C., and KOHANE, I.S. (2002). Newborn screening program practices in the United States: notification, research, and consent. Pediatrics 109, 29-273.
19. MARSHAL, E. (2001). Fast technology drives new world of newborn screening. Science 294, 2272-2274.
20. McCABE, E.R.B., HUANG, S.-Z., SELTZER, W.K., and LAW, M.L. (1987). DNA micro-extraction from dried blood spots on filter paper blotters: potential applications to newborn screening. Hum. Genet. 75, 213-216.
21. MOTZFELD, K., LILJE, R., and NYLANDER, G. (1999). Breast feeding in phenylketonuria. Acta Pediatr. 88 (Suppl. 432), 25-27.
22. PELIAS, M.K., and MARKWARD, N.J. (2001). Newborn screening, informed consent, and future use of archived tissue samples. Genet. Test. 5, 179-185.
23. PETERSEN, E., and EATON, R.B. (1999). Control of congenital infection with Toxoplasmosis gondii by neonatal screening based on detection of specific immunoglobulin M antibodies eluted from phenylketonuria filter-paper blood-spot samples. Acta Pediatr. 88 (Suppl. 432), 36-39.
24. ROSES, A.D. (2000). Pharmacogenetics and the practice of medicine. Nature 405, 857-865.
25. TOUBLANE, J.E. (1999). Guidelines for neonatal screening programs for congenital hypothyroidism. Acta Pediatr. 88 (Suppl. 432), 13-14.
26. WEBSTER, D., DHONDT, J.L., HANNON, W.H., LOEBER, G., and TORRESANI, T. (1999). Quality assurance and standardization: summary of satellite meeting, Turku, Finland, 11-12 June 1999 Acta Pediatr. 88 (Suppl. 432), 7-12.
27. WILKEN, B., and TRAVERT, G. (1999). Neonatal screening for cystic fibrosis: present and future. Acta Pediatr. 432, 33-35.